Marwan Noel Sabbagh's most recent trade in CervoMed Inc was a trade of 8,100 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CervoMed Inc | Marwan Noel Sabbagh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2025 | 8,100 | 8,100 | - | - | Stock Option (Right to Buy) | |
| CervoMed Inc | Marwan Noel Sabbagh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 5,750 | 5,750 | - | - | Stock Option (Right to Buy) | |
| Quince Therapeutics Inc | Marwan Noel Sabbagh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2022 | 22,058 | 22,058 | - | - | Stock Option (right to buy) |